Kyle Haynes, Director at OncoSil Medical Ltd, holds 6.65M shares in OncoSil Medical Ltd (Ticker: AU:OSL). Most recently, Kyle Haynes Sold AU$188,337 shares of OncoSil Medical Ltd on Jan 20, 2012 for an estimated value of 6.08K.
What is the percentage of profitable transactions made by Kyle Haynes?
The percentage of profitable transactions made by Kyle Haynes is 33%.
What is the average return per transaction made by Kyle Haynes?
The average return per transaction made by Kyle Haynes is -2.60%.
What stocks does Kyle Haynes hold?
Kyle Haynes holds: AU:OSL stocks.
What was Kyle Haynes’s latest transaction?
Kyle Haynes latest transaction was an Informative Sell of AU$6.08K.
What was Kyle Haynes's most profitable transaction?
Kyle Haynes’s most profitable transaction was an Informative Sell of AU:OSL stock on January 20, 2012. The return on the trade was 20.00%.
What is Kyle Haynes's role in OncoSil Medical Ltd?
Kyle Haynes's role in OncoSil Medical Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.